Related Experiment Video

Updated: Jun 28, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

The role of the PI3K-AKT kinase pathway in T-cell development beyond the beta checkpoint

Ling Xue1, Leslie Chiang, Chulho Kang

  • 1Cancer Research Laboratory, University of California, Berkeley, CA 94720, USA.

European Journal of Immunology
|November 11, 2008
PubMed

Insights

The PI3K-AKT pathway is vital for T-cell development, controlling the transition to double-positive thymocytes. This pathway is essential for this specific T-cell stage but not for apoptosis or maturation.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • The Phosphatidylinositol 3-kinase-AKT (PI3K-AKT) pathway regulates immune responses and lymphocyte development.
  • Previous studies suggest PI3K-AKT involvement in T-cell development, particularly in anti-apoptosis and regulatory T-cell generation.
  • The role of endogenous PI3K-AKT in T-cell development post-TCR-beta checkpoint remains largely unknown.

Purpose of the Study:

  • To investigate the function of the endogenous PI3K-AKT pathway in T-cell development after the double-negative stage.
  • To determine the specific role of PI3K-AKT in the transition from intermediate single positive to double-positive (DP) thymocytes.

Main Methods:

  • Inhibition of the endogenous PI3K-AKT pathway in thymocytes by expressing the PTEN (Phosphatase and tensin homolog) tumor suppressor.
  • Analysis of T-cell development stages, including intermediate single positive, DP thymocytes, and peripheral T cells.
  • Assessment of thymocyte apoptosis, proliferation, and T-cell maturation, including regulatory T cells.

Main Results:

  • Normal early T-cell development was observed.
  • Inhibition of PI3K-AKT significantly impaired the transition from intermediate single positive to DP thymocytes.
  • Reduced numbers of DP thymocytes, single positive thymocytes, and peripheral T cells were found.
  • Peripheral T-cell proliferation was decreased, but DP cell apoptosis and T-cell maturation were unaffected.

Conclusions:

  • The PI3K-AKT pathway is critical for the transition of intermediate single positive thymocytes to DP thymocytes.
  • Endogenous PI3K-AKT signaling is dispensable for apoptosis and maturation of developing thymocytes.
  • TCR activation-induced AKT phosphorylation is absent in DP thymocytes, suggesting context-specific pathway roles.

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...